203 related articles for article (PubMed ID: 21793070)
1. Molecular imaging of tumor invasion and metastases: the role of MRI.
McCann TE; Kosaka N; Turkbey B; Mitsunaga M; Choyke PL; Kobayashi H
NMR Biomed; 2011 Jul; 24(6):561-8. PubMed ID: 21793070
[TBL] [Abstract][Full Text] [Related]
2. Imaging Tumor Metastases with Molecular Probes.
Qiao R; Zhu R; Gao M
Curr Pharm Des; 2015; 21(42):6260-4. PubMed ID: 26503140
[TBL] [Abstract][Full Text] [Related]
3. The Precise Diagnosis of Cancer Invasion/Metastasis via 2D Laser Ablation Mass Mapping of Metalloproteinase in Primary Cancer Tissue.
Zhang X; Liu R; Yuan Q; Gao F; Li J; Zhang Y; Zhao Y; Chai Z; Gao L; Gao X
ACS Nano; 2018 Nov; 12(11):11139-11151. PubMed ID: 30359513
[TBL] [Abstract][Full Text] [Related]
4. Fast Dixon whole-body MRI for detecting distant cancer metastasis: a preliminary clinical study.
Costelloe CM; Kundra V; Ma J; Chasen BA; Rohren EM; Bassett RL; Madewell JE
J Magn Reson Imaging; 2012 Feb; 35(2):399-408. PubMed ID: 21990095
[TBL] [Abstract][Full Text] [Related]
5. Molecular and functional imaging of invasion and metastasis: windows into the metastatic cascade.
Stasinopoulos I; Penet MF; Krishnamachary B; Bhujwalla ZM
Cancer Biomark; 2010; 7(4):173-88. PubMed ID: 21576811
[TBL] [Abstract][Full Text] [Related]
6. Development and
Ma XH; Wang S; Liu SY; Chen K; Wu ZY; Li DF; Mi YT; Hu LB; Chen ZW; Zhao XM
World J Gastroenterol; 2019 Jun; 25(24):3030-3043. PubMed ID: 31293339
[TBL] [Abstract][Full Text] [Related]
7. Molecular Imaging of Breast Cancer: Role of RGD Peptides.
Chakravarty R; Chakraborty S; Dash A
Mini Rev Med Chem; 2015; 15(13):1073-94. PubMed ID: 26349490
[TBL] [Abstract][Full Text] [Related]
8. Predictive ability of maximal tumor diameter on MRI for high-risk endometrial cancer.
Bourgioti C; Chatoupis K; Tzavara C; Antoniou A; Rodolakis A; Moulopoulos LA
Abdom Radiol (NY); 2016 Dec; 41(12):2484-2495. PubMed ID: 27714421
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of high resolution whole-body MRI using parallel imaging and PET-CT. First experiences with a 32-channel MRI system].
Schmidt GP; Baur-Melnyk A; Tiling R; Hahn K; Reiser MF; Schoenberg SO
Radiologe; 2004 Sep; 44(9):889-98. PubMed ID: 15349732
[TBL] [Abstract][Full Text] [Related]
10. Unenhanced whole-body MRI versus PET-CT for the detection of prostate cancer metastases after primary treatment.
Barchetti F; Stagnitti A; Megna V; Al Ansari N; Marini A; Musio D; Monti ML; Barchetti G; Tombolini V; Catalano C; Panebianco V
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3770-3776. PubMed ID: 27735042
[TBL] [Abstract][Full Text] [Related]
11. Whole-body MRI including diffusion-weighted MRI compared with 5-HTP PET/CT in the detection of neuroendocrine tumors.
Carlbom L; Caballero-Corbalán J; Granberg D; Sörensen J; Eriksson B; Ahlström H
Ups J Med Sci; 2017 Mar; 122(1):43-50. PubMed ID: 27894208
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of rheumatoid arthritis with magnetic resonance imaging.
Gu JT; Nguyen L; Chaudhari AJ; MacKenzie JD
Top Magn Reson Imaging; 2011 Apr; 22(2):61-9. PubMed ID: 22648081
[TBL] [Abstract][Full Text] [Related]
13. A two-way comparison of whole-body 18FDG PET-CT and whole-body contrast-enhanced MRI for distant metastasis staging in patients with malignant tumors: a meta-analysis of 13 prospective studies.
Li J; Zhou H; Zhang X; Song F; Pang X; Wei Z
Ann Palliat Med; 2020 Mar; 9(2):247-255. PubMed ID: 32233618
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive estimation of prostate cancer aggressiveness using diffusion-weighted MRI and 3D proton MR spectroscopy at 3.0 T.
Thörmer G; Otto J; Horn LC; Garnov N; Do M; Franz T; Stolzenburg JU; Moche M; Kahn T; Busse H
Acta Radiol; 2015 Jan; 56(1):121-8. PubMed ID: 24504488
[TBL] [Abstract][Full Text] [Related]
15. Imaging of distant metastases of prostate cancer.
Pesapane F; Czarniecki M; Suter MB; Turkbey B; Villeirs G
Med Oncol; 2018 Sep; 35(11):148. PubMed ID: 30218382
[TBL] [Abstract][Full Text] [Related]
16. Dual-Modality Activity-Based Probes as Molecular Imaging Agents for Vascular Inflammation.
Withana NP; Saito T; Ma X; Garland M; Liu C; Kosuge H; Amsallem M; Verdoes M; Ofori LO; Fischbein M; Arakawa M; Cheng Z; McConnell MV; Bogyo M
J Nucl Med; 2016 Oct; 57(10):1583-1590. PubMed ID: 27199363
[TBL] [Abstract][Full Text] [Related]
17. Heading toward Macromolecular and Nanosized Bioresponsive MRI Probes for Successful Functional Imaging.
Angelovski G
Acc Chem Res; 2017 Sep; 50(9):2215-2224. PubMed ID: 28841293
[TBL] [Abstract][Full Text] [Related]
18. Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer.
Fasmer KE; Bjørnerud A; Ytre-Hauge S; Grüner R; Tangen IL; Werner HM; Bjørge L; Salvesen ØO; Trovik J; Krakstad C; Haldorsen IS
Acta Radiol; 2018 Aug; 59(8):1010-1017. PubMed ID: 29137496
[TBL] [Abstract][Full Text] [Related]
19. Spatial distribution of malignant tissue in gliomas: correlations of 11C-L-methionine positron emission tomography and perfusion- and diffusion-weighted magnetic resonance imaging.
Tietze A; Boldsen JK; Mouridsen K; Ribe L; Dyve S; Cortnum S; Østergaard L; Borghammer P
Acta Radiol; 2015 Sep; 56(9):1135-44. PubMed ID: 25270372
[TBL] [Abstract][Full Text] [Related]
20. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
[Next] [New Search]
